|
ZNF451 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.983700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.525600E-02 |
| Normal-vs-Stage2 |
1.722180E-01 |
| Normal-vs-Stage3 |
1.044480E-04 |
| Normal-vs-Stage4 |
3.63740000008939E-07 |
| Stage1-vs-Stage2 |
8.035600E-01 |
| Stage1-vs-Stage3 |
1.111900E-02 |
| Stage1-vs-Stage4 |
1.369230E-04 |
| Stage2-vs-Stage3 |
2.827800E-01 |
| Stage2-vs-Stage4 |
7.051900E-02 |
| Stage3-vs-Stage4 |
1.937640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.580900E-04 |
| Normal-vs-AfricanAmerican |
1.235590E-03 |
| Normal-vs-Asian |
6.395400E-01 |
| Caucasian-vs-AfricanAmerican |
3.964400E-01 |
| Caucasian-vs-Asian |
1.816650E-01 |
| AfricanAmerican-vs-Asian |
5.793900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.799400E-04 |
| Normal-vs-Female |
1.996370E-02 |
| Male-vs-Female |
1.574170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.404600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.961800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.775500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.811700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.384200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.106200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.324400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.116400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.985800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.238400E-01 |
| Normal-vs-Grade 2 |
2.474600E-01 |
| Normal-vs-Grade 3 |
1.89081999999452E-05 |
| Normal-vs-Grade 4 |
8.41390002115361E-09 |
| Grade 1-vs-Grade 2 |
4.321200E-01 |
| Grade 1-vs-Grade 3 |
8.179100E-03 |
| Grade 1-vs-Grade 4 |
2.030800E-04 |
| Grade 2-vs-Grade 3 |
5.191900E-04 |
| Grade 2-vs-Grade 4 |
1.74299999988747E-07 |
| Grade 3-vs-Grade 4 |
7.341100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.405000E-01 |
| Normal-vs-ccB subtype |
1.237940E-04 |
| ccA subtype-vs-ccB subtype |
1.416400E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.802150E-02 |
| Normal-vs-N1 |
4.140400E-03 |
| N0-vs-N1 |
1.373050E-01 |
|
|
